Literature DB >> 9606182

Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.

I Kitabayashi1, A Yokoyama, K Shimizu, M Ohki.   

Abstract

The AML1 transcription factor and the transcriptional coactivators p300 and CBP are the targets of chromosome translocations associated with acute myeloid leukemia and myelodysplastic syndrome. In the t(8;21) translocation, the AML1 (CBFA2/PEBP2alphaB) gene becomes fused to the MTG8 (ETO) gene. We previously found that the terminal differentiation step leading to mature neutrophils in response to granulocyte colony-stimulating factor (G-CSF) was inhibited by the ectopic expression of the AML1-MTG8 fusion protein in L-G murine myeloid progenitor cells. We show here that overexpression of normal AML1 proteins reverses this inhibition and restores the competence to differentiate. Immunoprecipitation analysis shows that p300 and CREB-binding protein (CBP) interact with AML1. The C-terminal region of AML1 is responsible for the induction of cell differentiation and for the interaction with p300. Overexpression of p300 stimulates AML1-dependent transcription and the induction of cell differentiation. These results suggest that p300 plays critical roles in AML1-dependent transcription during the differentiation of myeloid cells. Thus, AML1 and its associated factors p300 and CBFbeta, all of which are targets of chromosomal rearrangements in human leukemia, function cooperatively in the differentiation of myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606182      PMCID: PMC1170639          DOI: 10.1093/emboj/17.11.2994

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  81 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

2.  Use of retroviral vectors for gene transfer and expression.

Authors:  A D Miller; D G Miller; J V Garcia; C M Lynch
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

3.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene.

Authors:  E Ogawa; M Maruyama; H Kagoshima; M Inuzuka; J Lu; M Satake; K Shigesada; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

4.  Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1).

Authors:  D E Zhang; K Fujioka; C J Hetherington; L H Shapiro; H M Chen; A T Look; D G Tenen
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 5.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

6.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

Authors:  P Liu; S A Tarlé; A Hajra; D F Claxton; P Marlton; M Freedman; M J Siciliano; F S Collins
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.

Authors:  T Kozu; H Miyoshi; K Shimizu; N Maseki; Y Kaneko; H Asou; N Kamada; M Ohki
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

9.  Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

Authors:  E Ogawa; M Inuzuka; M Maruyama; M Satake; M Naito-Fujimoto; Y Ito; K Shigesada
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

10.  The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.

Authors:  H Miyoshi; T Kozu; K Shimizu; K Enomoto; N Maseki; Y Kaneko; N Kamada; M Ohki
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  83 in total

1.  Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.

Authors:  R Fenrick; J M Amann; B Lutterbach; L Wang; J J Westendorf; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Authors:  R Yagi; L F Chen; K Shigesada; Y Murakami; Y Ito
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Activation of Mouse Tcrb: Uncoupling RUNX1 Function from Its Cooperative Binding with ETS1.

Authors:  Jiang-Yang Zhao; Oleg Osipovich; Olivia I Koues; Kinjal Majumder; Eugene M Oltz
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

6.  The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.

Authors:  Andreas Müller-Schiffmann; Julia Beckmann; Gertrud Steger
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

8.  Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.

Authors:  David Merrick; Kavita Mistry; Jingshing Wu; Nikolay Gresko; Julie E Baggs; John B Hogenesch; Zhaoxia Sun; Michael J Caplan
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

9.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

Authors:  J Wang; T Hoshino; R L Redner; S Kajigaya; J M Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 10.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.